Company intelligence / Profile preview

Project Farma

Chicago, Illinois, United Statesprojectfarma.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Project Farma has pioneered the industrialization of advanced therapeutics by leading over 100 facility builds with capital investments exceeding $6 billion. The company has supported the commercial approval of first-in-class cell and gene therapies, radioligand therapies, RNA-based medicines, and other cutting-edge biologic products. It provides consulting services spanning project management to regulatory compliance for life sciences organizations globally.

Modalities: Cell therapyGene therapyRadioligand therapyBiologics (including complex biologics)RNA-based therapies
Industry: Consulting

Partnerships

Precision Medicine Group/Precision for Medicine (former parent)PerkinElmer OneSource Professional Services division (current integration)

Beyond the preview

Go deeper on Project Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Project Farma.

Explore the full profile